/CBDNF

CBDNF Stock - CBD Global Sciences Inc.

Q: What is the analyst price target for CBDNF?

Analyst price target information is not currently available for CBDNF.

Q: What is CBDNF's market cap?

Market capitalization information is not currently available for CBDNF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.04-2.67%

$0.00 (-2.67%) • Nov 27

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.05

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CBDNF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.43

52W High$0.12

52W Low$0.02

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2021	FY2020	FY2019
Revenue	$166,947	$305,400	$2.32M
Gross Profit	$40,999	$-187,061	$1.43M
Gross Margin	24.6%	-61.3%	61.9%
Operating Income	$-2,739,944	$-2,652,476	$-2,367,975
Net Income	$-5,252,701	$-8,927,702	$-8,956,222
Net Margin	-3146.3%	-2923.3%	-386.5%
EPS	$-0.15	$-0.28	$-0.53

Company Overview

CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.

Visit Website

Earnings History & Surprises

CBDNF

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.01

Q3 2022

EPS Surprise History

Q4 20

No data

Q1 21

No data

Q2 21

No data

Q4 21

No data

Q4 21

No data

Q1 22

No data

Q2 22

No data

Q3 22

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2022	Sep 30, 2022	—	$-0.01	—	—
Q2 2022	Jun 30, 2022	—	$-0.01	—	—
Q1 2022	Mar 31, 2022	—	$-0.01	—	—
Q4 2021	Dec 31, 2021	—	$-0.04	—	—
Q4 2021	Nov 29, 2021	—	$0.10	—	—
Q2 2021	Jun 30, 2021	—	$-0.02	—	—
Q1 2021	Mar 31, 2021	—	$-0.04	—	—
Q4 2020	Dec 31, 2020	—	$-0.07	—	—
Q3 2020	Sep 30, 2020	—	$-0.06	—	—
Q2 2020	Jun 30, 2020	—	$-0.04	—	—
Q1 2020	Mar 31, 2020	—	$-0.02	—	—
Q4 2019	Dec 31, 2019	—	$-0.13	—	—
Q3 2019	Sep 30, 2019	—	$-0.09	—	—

Frequently Asked Questions about CBDNF

What is CBDNF's current stock price?

CBD Global Sciences Inc. (CBDNF) is currently trading at $0.04 per share. The stock has moved -2.67% today.

What is the analyst price target for CBDNF?

No analyst price targets are currently available for this stock.

What sector is CBD Global Sciences Inc. in?

CBD Global Sciences Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is CBDNF's market cap?

CBD Global Sciences Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does CBDNF pay dividends?

No, CBD Global Sciences Inc. does not currently pay a dividend to shareholders.